3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
17
Fallopian Tube Neoplasms
17
Carcinoma, Non-Small-Cell Lung
8
Glioblastoma
7
Carcinoma, Renal Cell
7
Lung Neoplasms
6
Colorectal Neoplasms
6
Brenner Tumor
6
Squamous Cell Carcinoma of Head and Neck
5
Melanoma
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Gliosarcoma
4
Breast Neoplasms
4
Brain Neoplasms
4
Recurrent Squamous Cell Lung Carcinoma
3
Oligodendroglioma
3
Neoplasm Metastasis
3
Lymphoma, Large B-Cell, Diffuse
3
Uveal Melanoma
2
Urinary Bladder Neoplasms
2
Spinal Cord Neoplasms
2
Medulloblastoma
2
Glioma
2
Endometrial Adenocarcinoma
2
Colonic Neoplasms
2
Carcinoma
2
Astrocytoma
2
Adenocarcinoma of Lung
2
Interventions
pazopanib
2
cediranib
2
Sunitinib
2
Ifosfamide
2
Doxorubicin
2
sargramostim
1
romidepsin
1
pembrolizumab
1
indolepropanol phosphate
1
cabozantinib
1
atropine sulfate-diphenoxylate hydrochloride drug combination
1
Watchful Waiting
1
Warfarin
1
Vitamin B 6
1
Thyroxine
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation
1
Pyridoxine
1
Promethazine
1
Prochlorperazine
1
Polymerase Chain Reaction
1
Petrolatum
1
Observation
1
Neoadjuvant Therapy
1
Lorazepam
1
Loperamide
1
HhAntag691
1
Gene Expression Profiling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Alveolar Soft Part
×
Immunoglobulin G
×
Clear all
No trials found.